
About Avigya Bio
Avigya Bio is a Healthcare company based in Hyderabad (India) founded in 2020. Contract research organization for pharmaceutical intermediates and specialty chemicals. It operates on a B2B model. The company has 14 employees. Its Indian entity Avigya Biosciences Private Limited reported revenue of βΉ10.85 Cr. Avigya Bio offers products and services including Process Chemistry, Synthetic Chemistry, Specialized Chemistry, Cefpodoxime, and Cefixime. Its focus areas include Pharmaceuticals, Intermediates, Specialty Chemicals and Agriculture.
Company details
Avigya Biosciences Is A Hyderabad, India-based Company That Operates As A Contract Research Organization In The Pharmaceutical Sector. It Offers Services Like Process Chemistry, Synthetic Chemistry, And Specialized Chemistry To Domestic And International Customers. The Firm Focuses On Developing Intermediates, Specialty Chemicals, Impurities, And Active Pharmaceutical Ingredients With Capabilities From Mg To Multi-kg Scale. It Emphasizes Quality, Competitive Pricing, And Expertise In Rd And Manufacturing, Serving Clients In Pharmaceuticals And Agro Chemicals.
- Headquarters Hyderabad, India
- Employees 14
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website avigyabio.com
- Legal Name Avigya Biosciences Private Limited
- Date of Incorporation 13 Jun, 2020
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹10.85 Cr
FY 2024 · +3% YoY
- Net Profit₹13.4 Lakh
FY 2024 · 1% margin
- EBITDA₹50.4 Lakh
FY 2024 · 5% margin
- Employee Count14
Associated legal entities of Avigya Bio
Avigya Bio operates through Avigya Biosciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Avigya Biosciences Private Limited CIN U36999TG2020PTC140818 | Active | 13 Jun 2020 | Hyderabad, Telangana | ₹10.9 Cr | 14 | 5 | View details |
Products & Services of Avigya Bio
Avigya Bio offers a comprehensive portfolio of products and services, including Process Chemistry, Synthetic Chemistry, Specialized Chemistry, Cefpodoxime, and Cefixime.
Service for developing chemical processes in pharmaceuticals.
Method for creating organic compounds for pharmaceutical use.
Tailored chemical solutions for impurities and intermediates.
Intermediate for antibiotic production in medical applications.
Chemical compound used as an active ingredient in antibiotics.
Board of directors of Avigya Biosciences Private Limited (Avigya Bio)
Avigya Biosciences Private Limited is the primary company behind Avigya Bio. The board of Avigya Biosciences Private Limited currently have 5 directors; the longest-serving is Ramakrishna Kamutam, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ramakrishna Kamutam DIN 07340489 | Director | 13 Jun 2020 | 6 yrs 5 mo | Avigya Biosciences Private Limited |
| Ravindar Kotla DIN 08761751 | Director | 13 Jun 2020 | 6 yrs 5 mo | Avigya Biosciences Private Limited |
| Radhika Gandam DIN 08910513 | Director | 11 Oct 2020 | 6 yrs 1 mo | Avigya Biosciences Private Limited |
| Mangalapally Jyothi DIN 09081511 | Director | 25 Feb 2021 | 5 yrs 8 mo | Avigya Biosciences Private Limited |
| Vijender Medamoni DIN 01594109 | Director | 23 Jan 2025 | 1 yr 9 mo | Avigya Biosciences Private Limited |
Financials of Avigya Bio
Figures of Avigya Biosciences Private Limited, the primary company behind Avigya Bio, for FY 2024. Revenue was ₹10.85 Cr (+3% year on year). Net profit was ₹13.4 Lakh (1% margin). EBITDA was ₹50.4 Lakh (5% margin). Revenue has grown at a compounded annual rate of +142% over three years.
- ₹10.85 CrRevenue · FY 2024 · +3% YoY
- ₹13.4 LakhNet profit · 1% margin
- ₹50.4 LakhEBITDA · 5% margin
- ₹1.60 CrPaid-up capital
- 14Employees (provident fund records)
- +142%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Avigya Biosciences Private Limited are on its company page.
Detailed financial statements for Avigya Bio
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Avigya Bio
Avigya Bio was founded in 2020.
Avigya Bio is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Avigya Bio has 14 employees.
The primary company behind Avigya Bio, Avigya Biosciences Private Limited, reported revenue of βΉ10.85 Cr for FY 2024, up 3% year on year.
Avigya Biosciences Is A Hyderabad, India-based Company That Operates As A Contract Research Organization In The Pharmaceutical Sector. It Offers Services Like Process Chemistry, Synthetic Chemistry, And Specialized Chemistry To Domestic And International Customers. The Firm Focuses On Developing Intermediates, Specialty Chemicals, Impurities, And Active Pharmaceutical Ingredients With Capabilities From Mg To Multi-kg Scale. It Emphasizes Quality, Competitive Pricing, And Expertise In Rd And Manufacturing, Serving Clients In Pharmaceuticals And Agro Chemicals.
Avigya Bio offers Process Chemistry, Synthetic Chemistry, Specialized Chemistry, Cefpodoxime, and Cefixime.
Avigya Bio operates through Avigya Biosciences Private Limited.
The legal entities of Avigya Bio currently have 5 directors, including Ramakrishna Kamutam, Radhika Gandam, Mangalapally Jyothi and others.